Bovine Spongiform Encephalopathy (Bse) is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Bovine Spongiform Encephalopathy (BSE), commonly known as "mad cow disease," is a fatal neurodegenerative disease affecting cattle. It is classified as a transmissible spongiform
encephalopathy (TSE) or Prion Disease, caused by the misfolding of the normal cellular prion protein (PrP^C) into an abnormal, pathogenic form (PrP^Sc)1. The disease is characterized by progressive cerebellar ataxia, behavioral changes, and eventual death. BSE is particularly
significant because it can cross species barriers to infect humans, causing variant Creutzfeldt-Jakob Disease (vCJD)2.
¶ History and Epidemiology
¶ Origin and Spread
BSE was first identified in the United Kingdom in 1986, though retrospective studies suggest the disease may have been present as early as the early 1980s3. The epidemic
peaked in 1992-1993 with approximately 1,000 new cases per week in the UK alone. By the time the epidemic was controlled through systematic culling of infected herds, over 180,000
cattle had been confirmed with BSE in the UK4.
The origin of BSE is believed to be from feed contamination. Cattle are naturally herbivores, but traditional farming practices included supplementing feed with meat-and-bone meal (MBM) derived from rendered animal tissues. It is hypothesized that the infectious agent originated from sheep infected with scrapie (a similar TSE in sheep) or from a spontaneous case of BSE in cattle that was then amplified through feed contamination5.
Following the UK outbreak, BSE cases were reported in other countries, primarily linked to imported UK cattle or contaminated feed:
- United Kingdom: 180,000+ cases (1986-2020)
- Ireland: 1,650+ cases
- France: 910+ cases
- Germany: 400+ cases
- Spain: 150+ cases
- Portugal: 100+ cases
- Japan: 36 cases
- United States: 4 cases (2003, 2005, 2006)
- Canada: 20+ cases
The implementation of feed bans (banning meat-and-bone meal in ruminant feed) in 1988 in the UK and subsequently worldwide led to a dramatic decline in new cases. The incubation period of BSE is typically 4-5 years, so cases continued to appear for years after the feed ban4.
BSE, like all prion diseases, is caused by the misfolding of the normal cellular prion protein (PrP^C) into an abnormal, protease-resistant isoform (PrP^Sc). This misfolded protein is exceptionally resistant to denaturation, heat, and radiation1.
The abnormal prion protein accumulates in the central nervous system, particularly in:
- Brainstem: The dorsal motor nucleus of the vagus nerve is one of the earliest and most affected regions
- Cerebellum: Responsible for the progressive ataxia characteristic of BSE
- Thalamus: Involved in sensory processing
- Cerebral cortex: Affected in later stages
The characteristic features of BSE in the brain include:
- Spongiform changes: Extensive vacuolation (sponge-like appearance) of the neuropil
- Neuronal loss: Death of neurons, particularly in the brainstem
- Gliosis: Proliferation of astrocytes (reactive gliosis)
- Prion protein deposition: Insoluble, protease-resistant prion protein aggregates throughout the brain
- Flambé neurons: Distended neuronal processes containing prion protein aggregates
BSE exists as multiple strains with different biological properties. Classical BSE (C-BSE) is the predominant form. Atypical BSE forms (H-BSE and L-BSE) were identified later and appear to occur spontaneously in older cattle, similar to sporadic CJD in humans6.
¶ Signs and Symptoms
BSE has an insidious onset with a progressive course. The clinical signs typically appear in cattle aged 4-7 years, though the infection occurs much earlier (around 6 months of age)7.
Neurological Signs:
- Ataxia: Progressive incoordination, particularly affecting the hind limbs
- Behavioral changes: Nervousness, aggression, or conversely, depression and apathy
- Hypersensitivity: Heightened reactions to touch, sound, or visual stimuli
- Tremors: Fine tremors of the head and neck
- Postural abnormalities: Difficulty rising, abnormal stance
Other Signs:
- Weight loss despite good appetite
- Reduced milk production in dairy cows
- Weight loss and muscle wasting in advanced disease Progression
The
¶ Disease clinical course of BSE is progressive and invariably fatal. Following the onset of neurological signs, deterioration occurs over weeks to months, with most animals being euthanized within 2-6 months of symptom onset7.
A presumptive diagnosis of BSE is based on:
- Clinical signs (progressive cerebellar ataxia in adult cattle)
- History and epidemiological factors
- Exclusion of other neurological diseases
Post-mortem tests are required for definitive diagnosis:
- Histopathology: Examination of brain tissue for spongiform changes, neuronal loss, and gliosis
- Immunohistochemistry: Detection of prion protein deposits in brain tissue
- Western blot: Detection of the abnormal, protease-resistant prion protein isoform (PrP^Sc)
- ELISA: Screening tests for prion protein detection
- RT-QuIC: Real-time quaking-induced conversion assay - highly sensitive detection of PrP^Sc
The primary route of BSE transmission was through consumption of contaminated feed containing infected animal tissue. The infectious agent is concentrated in neural tissue (brain, spinal cord) and, to a lesser extent, in lymphoid tissue5.
Key transmission factors:
- Feed contaminated with meat-and-bone meal from infected animals
- The infectious agent is extremely resistant to standard rendering processes
- Low infectious dose required to cause disease
There is no evidence of significant vertical (maternal) transmission of BSE from cow to calf4.
BSE has demonstrated the ability to cross species barriers:
- Humans: Causes variant CJD (vCJD) through consumption of contaminated beef products
- Cats (FSE): Feline spongiform encephalopathy in domestic cats
- Exotic ungulates: Cases in captive wildcats (kudu, nyala, oryx)
- Primates: Experimental transmission to non-human primates
The most significant public health consequence of BSE is its link to variant CJD in humans. vCJD was first described in 1996 and is causally linked to consumption of BSE-contaminated beef products2.
Key features of vCJD:
- Younger age of onset (average 28 years) compared to sporadic CJD (65 years)
- Prolonged clinical course (median 14 months)
- Psychiatric symptoms (depression, anxiety, hallucinations) prominent early
- Progressive cerebellar ataxia and cognitive decline
- Distinctive "pulvinar sign" on MRI
As of 2024, there have been approximately 230 confirmed vCJD cases worldwide, with the majority (178) in the United Kingdom8.
¶ Blood and Tissue Transmission
vCJD has been transmitted through:
- Blood transfusions (4 cases in the UK)
- Plasma-derived products
- Dura mater grafts
- Corneal transplants
This has led to significant changes in blood donation policies in affected countries.
¶ Control and Eradication
The cornerstone of BSE control has been the prohibition of meat-and-bone meal (MBM) in ruminant feed:
- UK feed ban (1988): Banned the use of ruminant-derived protein in ruminant feed
- EU-wide feed ban (1994): Extended to ban all mammalian-derived protein in feed for farm animals
- Specified Risk Materials (SRM): Mandatory removal and destruction of high-risk tissues (brain, spinal cord, tonsils, ileum) from the food chain
Active surveillance programs test brain samples from:
- Dead, dying, or diseased cattle ("fallen stock")
- Healthy animals at slaughter
- Animals displaying neurological signs
Compulsory culling of herds with confirmed BSE cases helped control the epidemic.
¶ Treatment and Prevention
There is currently no treatment for BSE or any other Prion Disease. All cases are fatal.
Prevention of BSE relies on:
- Feed safety measures: Elimination of animal-derived protein from cattle feed
- Surveillance: Testing of high-risk animals
- Specified Risk Material removal: Exclusion of neural tissues from the food chain
- Import controls: Restrictions on cattle and beef products from BSE-affected countries
- Human vCJD prevention: Blood donation deferrals for at-risk individuals
The study of Bovine Spongiform Encephalopathy (Bse) has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- [Prusiner SB. Prions. Proc Natl Acad Sci USA. 1998;95(21):13363-13383. DOI
- [Hill AF, Desbruslais M, Joiner S, et al. The same prion strain causes vCJD and BSE. Nature. 1997;389(6650):448-450. DOI
- [Wells GA, Scott AC, Johnson CT, et al. A novel progressive spongiform encephalopathy in cattle. Vet Rec. 1987;121(18):419-420. DOI
- [Arnold ME, Wilesmith JW. Estimation of the age-dependent risk of infection to BSE of dairy cattle in Great Britain. Prev Vet Med. 2004;66(1-4):35-47. DOI
- [Colchester AC, Colchester NT. The origin of bovine spongiform encephalopathy: the role of meat supplements. Lancet. 2005;366(9484):410-411. DOI
- [Biacabé AG, Chapman RJ, Thuring ZS, et al. Phenotypic characterization of two unusual BSE strains. J Pathol. 2007;212(2):156-165. DOI
- [Braun U, Schicker E, Hornlimann B. Clinical findings in cattle with bovine spongiform encephalopathy. J Vet Med A Physiol Pathol Clin Med. 1998;45(6):333-338. DOI
- [WHO. Variant Creutzfeldt-Jakob Disease. Fact sheet